AlphAIAlphAI — Financial news for AI agents
finance.yahoo.comOCT 62 min read$OPCH

Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid

Option Care Health (OPCH) surged 33% to $31.11 after announcing a $5.8B acquisition by CD&R and McKesson at a 37% premium. The deal, expected to close in 2027, values OPCH at $32.05 per share. The company will delist from Nasdaq. Hedge fund holdings fell 42% QoQ despite more funds establishing positions. Q3 earnings, due Nov 4, 2026, will not include guidance.

Original reporting
finance.yahoo.com
Published Oct 6, 2026, 7:45 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 6, 2026, 7:56 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
Option Care Health (OPCH) Rockets as CD&R, McKesson Table 37% Premium Bid — source image
Source · finance.yahoo.com
Decision brief

The 30-second read

$OPCHBullishHigh
01

Why it matters

The deal creates a combined platform for home and ambulatory infusion, expanding patient access and potentially improving margins.

02

Market read

The announcement triggered a 33% intraday rally in OPCH and signals strategic expansion for McKesson in specialty infusion services.

03

What to watch

Regulatory approval timelines and potential antitrust scrutiny could delay closing.

Relevance 9/10Novelty 9/10Timing: today

Background

Option Care Health provides infusion therapy services; CD&R is a private‑equity firm; McKesson is a major health‑care distributor.

Company-level read

Ticker impact

$OPCHBullishHigh confidence
Context

Option Care Health announced a definitive agreement to be acquired by CD&R and McKesson at a 37% premium, sending the stock up 33% on the day.

Expected impact

upward pressure as the market prices in the acquisition premium

Evidence & confidence

First‑report of a $5.8 B deal with a large premium; the stock jumped 33% on the news.

$MCKNeutralMedium confidence
Context

McKesson is a 49% partner in the consortium acquiring Option Care Health for $5.8 B.

Expected impact

slight upside as investors view the strategic expansion positively

Evidence & confidence

Deal adds a new business line; impact on McKesson’s share price is secondary to the primary target.

Market effects

Sector

Consolidation in the infusion‑therapy and specialty‑care sector may spur further M&A activity.

Regional

U.S. healthcare services market sees a notable transaction, modestly affecting related peers.

Global

Large‑scale health‑care deal highlights continued private‑equity involvement in U.S. biotech.

Counterpoint

What could challenge this read

The premium may be excessive; integration risks could pressure post‑close performance.

Key entities

  • company
    Option Care Health

    Listed infusion‑therapy provider being acquired.

  • private_equity
    Clayson, Dubilier & Rice LLC

    Lead private‑equity sponsor acquiring 51% stake.

  • company
    McKesson Corp.

    Health‑care distributor acquiring 49% stake.

Read at source← All news

StoryCD&R and McKesson agree to acquire Option Care Health

Also covered by

4 outlets

Related articles

OCT 30
$BTSGHighAI 9/10

BrightSpring Soars 12% on Q3 Beat and Raised 2026 Guidance as Adjusted EBITDA Jumps 42%

BrightSpring Health Services (BTSG) stock rose 12% after Q3 earnings beat estimates, with revenue up 26% to $4.21B and adjusted EBITDA up 42% to $228M. The company raised its 2026 guidance. Gross profit per script increased 27%, and home health census grew 58% due to acquisitions from UnitedHealth's Amedisys and LHC Group. Option Care Health (OPCH) and CVS Health (CVS) report next week, which may indicate if BrightSpring's pricing gains are industry-wide.

finance.yahoo.com6 min
OCT 27
$MCKLow

Built and Bred

McKesson (MCK) will invest $179M in a 330,000 sq. ft. regional distribution center in Moore, Oklahoma, creating 200+ jobs. The site's location, readiness, and regional coordination influenced the decision, according to the company.

citylifestyle.com2 min
OCT 10
$OPCHMed

Key deals this week: Option Care Health, PTC, Energy Transfer and more

Service Properties Trust (SSVC) received a $2.0B acquisition offer from TKO LLC. Viatris (VTRS) agreed to buy Pacira BioSciences (PCRX) for $1.65B. Option Care Health (OPCH) surged 34% after a $5.8B acquisition deal with CD&R and McKesson (MCK). Energy Transfer (ET) will acquire Vaquero Midstream for $2.625B. Emera (EMA) and Canadian Utilities (CDUAF) agreed to a $10B merger. Cenovus Energy (CVE) will acquire Athabasca Oil (ATHOF) for ~$5.7B.

tradingview.com1 min
OCT 10
$OPCHHighAI 9/10

Option Care Health Sold for $5.8B in CD&R-McKesson Deal

Option Care Health (OPCH) is being acquired by CD&R and McKesson (MCK) for $5.8B, or $32.05 per share, a 37% premium. The deal, expected to close in 2027, values the company at $5.8B. Option Care Health will operate independently post-acquisition. The company reported $5.6B in 2025 revenue and $207.6M in net income, with modest growth in 2026. The acquisition aligns with McKesson's strategy to expand access to innovative therapies.

hoodline.com2 min
OCT 9
$MCKHighAI 9/10

McKesson (MCK) Joins $5.8 Billion Option Care Health (OPCH) Acquisition. Is the Valuation Justified?

McKesson (MCK) is acquiring Option Care Health (OPCH) for $5.8B, including debt, at $32.05 per share, a 37% premium. McKesson and private equity firm CD&R will own 49% and 51% respectively. The deal expands McKesson's specialty healthcare services. McKesson's Q1 2027 revenue was $105.4B, beating estimates, with adjusted EPS up 20% YoY to $9.93. The company raised its fiscal 2027 adjusted EPS guidance to $44.20-$45.00.

finance.yahoo.com2 min